217 related articles for article (PubMed ID: 7907572)
1. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil.
Allison AC; Eugui EM
Immunol Rev; 1993 Dec; 136():5-28. PubMed ID: 7907572
[No Abstract] [Full Text] [Related]
2. The design and development of an immunosuppressive drug, mycophenolate mofetil.
Allison AC; Eugui EM
Springer Semin Immunopathol; 1993; 14(4):353-80. PubMed ID: 8322167
[No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil and its mechanisms of action.
Allison AC; Eugui EM
Immunopharmacology; 2000 May; 47(2-3):85-118. PubMed ID: 10878285
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive activity of mycophenolate mofetil.
Eugui EM; Allison AC
Ann N Y Acad Sci; 1993 Jun; 685():309-29. PubMed ID: 8363235
[No Abstract] [Full Text] [Related]
5. Enteric-coated mycophenolate sodium: an update.
Zhang W; Ding C; Zheng S
Int J Clin Pract Suppl; 2014 Apr; (181):1-3. PubMed ID: 24673712
[No Abstract] [Full Text] [Related]
6. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
Allison AC; Eugui EM
Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].
Yashima Y; Ohgane T
Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):131-7. PubMed ID: 11233304
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil: a unique immunosuppressive agent.
Hood KA; Zarembski DG
Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
[TBL] [Abstract][Full Text] [Related]
10. In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443.
Allison AC; Almquist SJ; Muller CD; Eugui EM
Transplant Proc; 1991 Apr; 23(2 Suppl 2):10-4. PubMed ID: 2063415
[No Abstract] [Full Text] [Related]
11. Mechanism of action of mycophenolate mofetil.
Ransom JT
Ther Drug Monit; 1995 Dec; 17(6):681-4. PubMed ID: 8588241
[TBL] [Abstract][Full Text] [Related]
12. [Review of a new immunosuppressive drug: enteric-coated mycophenolate sodium (Myfortic)].
Sánchez-Fructuoso AI
Nefrologia; 2005; 25(3):234-42, 244. PubMed ID: 16053004
[No Abstract] [Full Text] [Related]
13. Mycophenolate mofetil as induction therapy after liver transplantation.
McDiarmid SV
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S85-9. PubMed ID: 10431021
[No Abstract] [Full Text] [Related]
14. Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection.
Simmons WD; Rayhill SC; Sollinger HW
Drug Saf; 1997 Aug; 17(2):75-92. PubMed ID: 9285199
[TBL] [Abstract][Full Text] [Related]
15. [Mycophenolate mofetil, a possible new immunosuppresant].
Weberová J; Voboril R; Semecký V
Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
[TBL] [Abstract][Full Text] [Related]
16. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.
Klupp J; van Gelder T; Dambrin C; Regieli JJ; Boeke K; Billingham ME; Morris RE
J Heart Lung Transplant; 2004 Mar; 23(3):334-51. PubMed ID: 15019644
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen.
Ohata K; Espinoza JL; Lu X; Kondo Y; Nakao S
Biol Blood Marrow Transplant; 2011 Feb; 17(2):205-13. PubMed ID: 20736080
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil: a report of the consensus panel.
Shaw LM; Sollinger HW; Halloran P; Morris RE; Yatscoff RW; Ransom J; Tsina I; Keown P; Holt DW; Lieberman R
Ther Drug Monit; 1995 Dec; 17(6):690-9. PubMed ID: 8588243
[No Abstract] [Full Text] [Related]
19. Lymphocyte-selective antiproliferative and immunosuppressive activity of mycophenolic acid and its morpholinoethyl ester (RS-61443) in rodents.
Eugui EM; Mirkovich A; Allison AC
Transplant Proc; 1991 Apr; 23(2 Suppl 2):15-8. PubMed ID: 2063416
[No Abstract] [Full Text] [Related]
20. From mice to man: the preclinical history of mycophenolate mofetil.
Sollinger HW
Clin Transplant; 1996 Feb; 10(1 Pt 2):85-92. PubMed ID: 8680054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
